August 2013 FDA Recall Drug by Nexus Pharmaceuticals Inc
D-925-2013 - Presence of particulate matter

This Class II drug recall was voluntarily initiated by Nexus Pharmaceuticals Inc on August 1, 2013 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-925-2013

Reason for Recall
Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.
Initiated
08-01-2013
Reported
09-04-2013
Quantity
46,185 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nexus Pharmaceuticals Inc
Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02

Batch or Lot Expiration Information

Lot# a) Lot: 112911, Exp. 11/13, b) Lot: 030712, Exp. 3/14